CD8A and neoplasm: At the same time, immunotherapy increases the number of cytotoxic CD8+ T cells and affects memory T cells in tumor infiltration by adjuvant-assisted recruitment of more DCs in the TME, or by blocking immune checkpoints to reduce immune regulation inhibition [80,81].